ASST Spedali Civili di Brescia

Brescia, Lombardy 25123

1 studies enrolling now · 9 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Chronic Heart Failure With Preserved Ejection Fraction, Chronic Heart Failure With Reduced Ejection Fraction, Heart Failure, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Relapsed/Refractory Multiple Myeloma

Studies at this site

• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma — Recruiting now
• Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) — Recruiting now
• Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] — Running, not enrolling
• Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy — Completed
• A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction — Completed
• REALIsM-HF Pilot Study — Completed
• Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed
• A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction — Completed
• A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction — Completed